Bogus claims found despite evasive tactics
This article was originally published in The Tan Sheet
Executive Summary
Michigan businessman Tony Pham faces up to 25 years in prison and $500,000 in fines after pleading guilty to fraudulently marketing dietary supplements online with illegal claims that the products could prevent, treat or cure diseases, including diabetes. The U.S. Attorney's Office for the Western District of Missouri said July 2 that Pham in 2005 and 2006 sold $11.95 million in supplements from Web sites operated by Techmedica Health, Inc., of Grand Rapids. Pham, who will forfeit his sales from those years, claimed six products were "proven reliable through clinical testing" for treating and preventing various diseases. He fabricated testimonials and professional endorsements, and impeded FDA's investigation by using "mirror image technology" to display a different version of his Web sites when accessed from FDA network computers, according to a release. Under FDA regulations, Techmedia's products are unapproved and misbranded drugs because their labels do not bear adequate directions for use. A sentencing hearing will be scheduled later
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.